STELLIAM INVESTMENT MANAGEMENT, LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 187 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
STELLIAM INVESTMENT MANAGEMENT, LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$19,923,000
-27.9%
572,500
-49.2%
0.66%
-28.4%
Q3 2016$27,635,000
+5.5%
1,127,500
+3.0%
0.92%
+2.1%
Q2 2016$26,192,000
-23.9%
1,095,000
-25.5%
0.91%
-14.9%
Q1 2016$34,398,000
+66.3%
1,470,000
+114.6%
1.06%
+72.6%
Q4 2015$20,680,000685,0000.62%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,921,550$81,254,0004.00%
Palo Alto Investors LP 1,614,536$33,453,0002.49%
Ghost Tree Capital, LLC 100,000$2,072,0001.46%
March Altus Capital Management LP 146,418$3,034,0001.11%
IRONWOOD INVESTMENT MANAGEMENT LLC 296,458$6,143,0000.98%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,339$20,706,0000.83%
Visium Asset Management, LP 2,070,870$42,908,0000.67%
AlphaOne Investment Services, LLC 97,448$2,019,0000.54%
CONTINENTAL ADVISORS LLC 57,438$1,190,0000.28%
Tamarack Capital Management, LLC 64,080$1,222,0000.25%
View complete list of AMAG PHARMACEUTICALS INC shareholders